Olha Halyabar, MD
Rheumatologist, Rheumatology Program
Assistant Professor of Pediatrics, Harvard Medical School
Image
Olha Halyabar, MD
Rheumatologist, Rheumatology Program
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Polish
Russian
Ukrainian
Education
Medical School
Danylo Halytsky Lviv National Medical University
2005
Lviv
Ukraine
Residency
Danylo Halytsky Lviv National Medical University
2007
Lviv
Ukraine
Internship
George Washington University
2013
Washington
DC
Residency
George Washington University
2015
Washington
DC
Fellowship
Boston Children's Hospital
2018
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Rheumatology)
Publications
Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis. View Abstract
T cell and autoantibody profiling for primary immune regulatory disorders. View Abstract
Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review. View Abstract
Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network. View Abstract
Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease. View Abstract
Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders. View Abstract
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome. View Abstract
Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis. View Abstract
Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. View Abstract
Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. View Abstract
Dr. Degar et al reply. View Abstract
Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study. View Abstract
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. View Abstract
Pediatric EVALI in the Age of COVID-19/MIS-C: Diagnostic Considerations. View Abstract
Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint. View Abstract
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis. View Abstract
Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. View Abstract
Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). View Abstract
A multidisciplinary assessment of pain in juvenile idiopathic arthritis. View Abstract
Assessing preparation for care transition among adolescents with rheumatologic disease: a single-center assessment with patient survey. View Abstract
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. View Abstract
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. View Abstract
WITHDRAWN: Complete Heart Block, Severe Ventricular Dysfunction and Myocardial Inflammation in a Child with COVID-19 Infection. View Abstract
Complete Heart Block, Severe Ventricular Dysfunction, and Myocardial Inflammation in a Child With COVID-19 Infection. View Abstract
On the Alert for Cytokine Storm: Immunopathology in COVID-19. View Abstract
Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. View Abstract
Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature. View Abstract
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. View Abstract
Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey. View Abstract
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. View Abstract
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. View Abstract
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. View Abstract
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. View Abstract
Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. View Abstract
CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation. View Abstract
Locations